Medical devices, healthcare technology and the business of care
510(k) clearance · K261392

TriActive Dental Implant System

Paragon Implant Mfg., LLC · Decision date Sep 17, 2026

MEDTECHLEDGER EXPLANATIONK261392

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision for K261392, the TriActive Dental Implant System, on 2026-09-17, with the application received 04/29/2026. The applicant is Paragon Implant Mfg., LLC of Calabasas, California, and the device falls under regulation 872.3640 as an endosseous, root-form implant with classification product code DZE and subsequent product code NHA. This is a 510(k) clearance, not a PMA approval.

The record describes the submission as an abbreviated summary reviewed by FDA rather than a third party, and it was not a combination product; no predetermined change control plan was authorized. The available material does not identify the predicate device, the specific components or changes submitted, or any performance data supporting equivalence, so the technical basis for the decision remains unknown from these sources.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Dental
Decision date
Sep 17, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K261392
Regulatory pathway
510(k) premarket notification
Product code
DZE
Decision code
SESE
Decision date
Sep 17, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Implant, Endosseous, Root-Form.

Product code
DZE
FDA device class
2

FDA decision timeline

  1. K261392 received

    Application receipt date recorded by FDA.

  2. K261392 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code DZE

Product / regulatory recordCompanyPathwayDecision dateSource
Alpha Bio Tec , Ltd.510(k) clearanceOct 22, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Paragon Implant Mfg., LLC

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Calabasas, CA

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records